[HTML][HTML] A delicate balance between antibody evasion and ACE2 affinity for Omicron BA. 2.75
Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have caused
successive global waves of infection. These variants, with multiple mutations in the spike …
successive global waves of infection. These variants, with multiple mutations in the spike …
[HTML][HTML] Evidence of escape of SARS-CoV-2 variant B. 1.351 from natural and vaccine-induced sera
The race to produce vaccines against severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) began when the first sequence was published, and this forms the basis for …
(SARS-CoV-2) began when the first sequence was published, and this forms the basis for …
[HTML][HTML] SARS-CoV-2 variant B. 1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
M Hoffmann, H Hofmann-Winkler, N Krüger, A Kempf… - Cell reports, 2021 - cell.com
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants
threatens efforts to contain the coronavirus disease 2019 (COVID-19) pandemic. The …
threatens efforts to contain the coronavirus disease 2019 (COVID-19) pandemic. The …
[HTML][HTML] BA. 2.12. 1, BA. 4 and BA. 5 escape antibodies elicited by Omicron infection
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron sublineages BA.
2.12. 1, BA. 4 and BA. 5 exhibit higher transmissibility than the BA. 2 lineage 1. The receptor …
2.12. 1, BA. 4 and BA. 5 exhibit higher transmissibility than the BA. 2 lineage 1. The receptor …
[HTML][HTML] Reduced neutralization of SARS-CoV-2 B. 1.617 by vaccine and convalescent serum
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has undergone
progressive change, with variants conferring advantage rapidly becoming dominant …
progressive change, with variants conferring advantage rapidly becoming dominant …
[HTML][HTML] SARS-CoV-2 B. 1.617 emergence and sensitivity to vaccine-elicited antibodies
Abstract The B. 1.617 variant emerged in the Indian state of Maharashtra in late 2020 and
has spread throughout India and to at least 40 countries. There have been fears that two key …
has spread throughout India and to at least 40 countries. There have been fears that two key …
[HTML][HTML] Antibody evasion by the P. 1 strain of SARS-CoV-2
Terminating the SARS-CoV-2 pandemic relies upon pan-global vaccination. Current
vaccines elicit neutralizing antibody responses to the virus spike derived from early isolates …
vaccines elicit neutralizing antibody responses to the virus spike derived from early isolates …
In vitro data suggest that Indian delta variant B. 1.617 of SARS‐CoV‐2 escapes neutralization by both receptor affinity and immune evasion
G Augusto, MO Mohsen, S Zinkhan, X Liu, M Vogel… - Allergy, 2022 - Wiley Online Library
Background Emerged mutations can be attributed to increased transmissibility of the B.
1.617 and B. 1.36 Indian delta variants of SARS‐CoV‐2, most notably substitutions …
1.617 and B. 1.36 Indian delta variants of SARS‐CoV‐2, most notably substitutions …
[HTML][HTML] Evasion of neutralizing antibody responses by the SARS-CoV-2 BA. 2.75 variant
P Qu, JP Evans, YM Zheng, C Carlin, LJ Saif, EM Oltz… - Cell host & …, 2022 - cell.com
Summary The newly emerged BA. 2.75 severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) variant contains 9 additional mutations in its spike (S) protein compared to …
(SARS-CoV-2) variant contains 9 additional mutations in its spike (S) protein compared to …
[HTML][HTML] Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to
emerge during the global pandemic and may facilitate escape from current antibody …
emerge during the global pandemic and may facilitate escape from current antibody …